Nano Packaged Tamoxifen and Curcumin; Effective Formulation against Sensitive and Resistant MCF-7 Cells

Tamoxifen is routinely used for treatment of Estrogen-positive breast carcinoma. Approximately, 50% of patients with metastatic cancer will develop resistance to Tamoxifen. In this research, Tamoxifen was combined with the anti-cancer compound Curcumin. Diblocknanopolymer was used to package the new...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Iran J Pharm Res
Main Authors: Hajigholami, Samira, Veisi Malekshahi, Ziba, Bodaghabadi, Narges, Najafi, Farhod, Shirzad, Hadi, Sadeghizadeh, Majid
Formato: Artigo
Idioma:Inglês
Publicado em: Shaheed Beheshti University of Medical Sciences 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5937073/
https://ncbi.nlm.nih.gov/pubmed/29755534
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados